Cover Image

Peripherally acting opioid receptor antagonists in pediatric patients

Saved in:

Bibliographic Details
Main Author:	Abhijit Nair (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020)

Targeting pain and inflammation by peripherally acting opioids
by: Christoph eStein
Published: (2013)

Butorphanol: Effects of a Prototypical Agonist-Antagonist Analgesic on κ-Opioid Receptors
by: Stephen Commiskey, et al.
Published: (2005)

In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
by: Kristina Puls, et al.
Published: (2022)

Peripheral-Type Benzodiazepine Receptor Antagonist Is Effective in Relieving Neuropathic Pain in Mice
by: Daisuke Kondo, et al.
Published: (2009)

Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test
by: Abigail Laman-Maharg, et al.
Published: (2018)

Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions
by: Katerina eIwaszkiewicz, et al.
Published: (2013)

Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists?
by: Adam M Kaye
Published: (2014)

Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5'-guanidinonaltrindole and the biased kappa opioid receptor agonist 6'-guanidinonaltrindole in mice
by: Alan Cowan, et al.
Published: (2021)

Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy
by: Rong Zhou, et al.
Published: (2018)

A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models
by: Rosamaria Lappano, et al.
Published: (2015)

Generalization of NMDA-Receptor Antagonists to the Discriminative Stimulus Effects of κ-Opioid Receptor Agonists U-50,488H, but Not TRK-820 in Rats
by: Tomohisa Mori, et al.
Published: (2006)

The therapeutic potential of ultra-short-acting β-receptor antagonists in perioperative analgesic: Evidence from preclinical and clinical studies
by: Linbin Fu, et al.
Published: (2022)

Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011)

Long-Acting Injectable naltrexone for the Management of patients with Opioid Dependence
by: Kimberly L. Kjome, et al.
Published: (2011)

Peripheral administration of SB223412, a selective neurokinin-3 receptor antagonist, suppresses pulsatile luteinizing hormone secretion by acting on the gonadotropin-releasing hormone pulse generator in estrogen-treated ovariectomized female goats
by: Takuya SASAKI, et al.
Published: (2020)

Opioids and Their Receptors Present and Emerging Concepts in Opioid Drug Discovery
Published: (2020)

The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome
by: Michel Alexander Steiner, et al.
Published: (2013)

Opioids and Their Receptors Present and Emerging Concepts in Opioid Drug Discovery II
Published: (2022)

NMDA Receptor Antagonists for Treatment of Depression
by: Zeynep Ates-Alagoz, et al.
Published: (2013)

Role of Leukotriene Receptor Antagonists in Asthma
by: Chih-Hsing Hung
Published: (2012)

Metabolic clearance of select opioids and opioid antagonists using hepatic spheroids and recombinant cytochrome P450 enzymes
by: Wing Y. Tuet, et al.
Published: (2022)

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons - Effects of Nerve Injury
by: Philip Stötzner, et al.
Published: (2018)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023)

Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
by: Yuki Moriya, et al.
Published: (2023)

Hyponatremia: A role for vasopressin receptor antagonists?
by: Gourishankar Ramesh
Published: (2018)

Orexin receptor antagonists as therapeutic agents for insomnia
by: Ana Clementina Equihua, et al.
Published: (2013)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Daiji Kawanami, et al.
Published: (2021)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
by: A. P. Pereverzev, et al.
Published: (2019)

Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
by: Cabanillas Stanchi KM, et al.
Published: (2020)

Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
by: Xin Wang, et al.
Published: (2021)

Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling
by: Pol Olga, et al.
Published: (2011)

Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice
by: Wei Chen, et al.
Published: (2017)

On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding
by: Daniel Hoyer, et al.
Published: (2024)

Opioid Antagonists May Reverse Endogenous Opiate "Dependence" in the Treatment of Self-Injurious Behavior
by: Curt A. Sandman, et al.
Published: (2011)

Comment on "Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review"
by: Todtenkopf Mark S. PhD, et al.
Published: (2023)

In Vivo Regulation of the μ Opioid Receptor: Role of the Endogenous Opioid Agents
by: Veronica Gonzalez-Nunez, et al.
Published: (2013)

Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study
by: Michael A Irvine, PhD, et al.
Published: (2018)

Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
by: Haiming Ma, et al.
Published: (2018)